Inclusion of Minority Patients in Breast Cancer Clinical Trials: The Role of the Clinical Trial Environment
Annual rept. 1 May 2008-30 Apr 2009
CALIFORNIA UNIV SAN FRANCISCO
Pagination or Media Count:
Clinical trials are the primary vehicle for transforming laboratory discoveries in breast cancer care into clinical practice. Enhanced participation by minorities in these trials is necessary to assess the effectiveness of advances in breast cancer care among major subpopulations and to ensure equity in the distribution of research benefits. However, minority participation in clinical trials will likely remain low without research designed to understand the reasons for limited participation. To address persistent ethnic and socioeconomic disparities in cancer care, including participation in research, interventions need to assess the broader context of clinical trials and include the larger community where these trials take place. Our study examines the combined effect of these factors on minority referral. The research team has completed all key research activities identifying all active breast cancer clinical trials in the four states CA, FL, IL and NY, identifying clinical trial research team members, obtaining datasets for key community indicators, identifying all breast cancer physicians, refining the data for preliminary analysis, finalizing all survey instruments, and completing physician surveys for all four states and the RTM surveys for California.
- Sociology and Law
- Medicine and Medical Research